242 related articles for article (PubMed ID: 11519538)
1. Ultrasound contrast agents: properties, principles of action, tolerance, and artifacts.
Correas JM; Bridal L; Lesavre A; Méjean A; Claudon M; Hélénon O
Eur Radiol; 2001; 11(8):1316-28. PubMed ID: 11519538
[TBL] [Abstract][Full Text] [Related]
2. Ultrasound contrast agents. Examples of blood pool agents.
Correas JM; Hélénon O; Pourcelot L; Moreau JF
Acta Radiol Suppl; 1997; 412():101-12. PubMed ID: 9240088
[TBL] [Abstract][Full Text] [Related]
3. The kidney: imaging with microbubble contrast agents.
Correas JM; Claudon M; Tranquart F; Hélénon AO
Ultrasound Q; 2006 Mar; 22(1):53-66. PubMed ID: 16641794
[TBL] [Abstract][Full Text] [Related]
4. Contrast ultrasound: general principles and veterinary clinical applications.
Ohlerth S; O'Brien RT
Vet J; 2007 Nov; 174(3):501-12. PubMed ID: 17412620
[TBL] [Abstract][Full Text] [Related]
5. Ultrasound contrast agents: basic principles.
Calliada F; Campani R; Bottinelli O; Bozzini A; Sommaruga MG
Eur J Radiol; 1998 May; 27 Suppl 2():S157-60. PubMed ID: 9652516
[TBL] [Abstract][Full Text] [Related]
6. In vitro contrast-enhanced ultrasound measurements of capillary microcirculation: comparison between polymer- and phospholipid-shelled microbubbles.
Grishenkov D; Kari L; Brodin LK; Brismar TB; Paradossi G
Ultrasonics; 2011 Jan; 51(1):40-8. PubMed ID: 20542310
[TBL] [Abstract][Full Text] [Related]
7. [Ultrasonographic contrast media].
Drudi F
Radiol Med; 2004 Apr; 107(4 Suppl 1):36-7. PubMed ID: 15323321
[No Abstract] [Full Text] [Related]
8. A Milestone: Approval of CEUS for Diagnostic Liver Imaging in Adults and Children in the USA.
Seitz K; Strobel D
Ultraschall Med; 2016 Jun; 37(3):229-32. PubMed ID: 27276056
[TBL] [Abstract][Full Text] [Related]
9. Effects of ultrasound contrast agents on Doppler tissue velocity estimation.
Ressner M; Brodin LA; Jansson T; Hoff L; Ask P; Janerot-Sjoberg B
J Am Soc Echocardiogr; 2006 Feb; 19(2):154-64. PubMed ID: 16455419
[TBL] [Abstract][Full Text] [Related]
10. The EFSUMB Guidelines and Recommendations on the Clinical Practice of Contrast Enhanced Ultrasound (CEUS): update 2011 on non-hepatic applications.
Piscaglia F; Nolsøe C; Dietrich CF; Cosgrove DO; Gilja OH; Bachmann Nielsen M; Albrecht T; Barozzi L; Bertolotto M; Catalano O; Claudon M; Clevert DA; Correas JM; D'Onofrio M; Drudi FM; Eyding J; Giovannini M; Hocke M; Ignee A; Jung EM; Klauser AS; Lassau N; Leen E; Mathis G; Saftoiu A; Seidel G; Sidhu PS; ter Haar G; Timmerman D; Weskott HP
Ultraschall Med; 2012 Feb; 33(1):33-59. PubMed ID: 21874631
[No Abstract] [Full Text] [Related]
11. Contrast-enhanced ultrasound using SonoVue® (sulphur hexafluoride microbubbles) compared with contrast-enhanced computed tomography and contrast-enhanced magnetic resonance imaging for the characterisation of focal liver lesions and detection of liver metastases: a systematic review and cost-effectiveness analysis.
Westwood M; Joore M; Grutters J; Redekop K; Armstrong N; Lee K; Gloy V; Raatz H; Misso K; Severens J; Kleijnen J
Health Technol Assess; 2013 Apr; 17(16):1-243. PubMed ID: 23611316
[TBL] [Abstract][Full Text] [Related]
12. Potentiating intra-arterial sonothrombolysis for acute ischemic stroke by the addition of the ultrasound contrast agents (Optison™ & SonoVue(®)).
Soltani A; Singhal R; Obtera M; Roy RA; Clark WM; Hansmann DR
J Thromb Thrombolysis; 2011 Jan; 31(1):71-84. PubMed ID: 20473551
[TBL] [Abstract][Full Text] [Related]
13. Phagocytosis of ultrasound contrast agent microbubbles by Kupffer cells.
Yanagisawa K; Moriyasu F; Miyahara T; Yuki M; Iijima H
Ultrasound Med Biol; 2007 Feb; 33(2):318-25. PubMed ID: 17207907
[TBL] [Abstract][Full Text] [Related]
14. Contrast echocardiography in critical care: echoes of the future? A review of the role of microsphere contrast echocardiography.
Platts DG; Fraser JF
Crit Care Resusc; 2011 Mar; 13(1):44-55. PubMed ID: 21355829
[TBL] [Abstract][Full Text] [Related]
15. Gene transfer with microbubble ultrasound and plasmid DNA into skeletal muscle of mice: comparison between commercially available microbubble contrast agents.
Wang X; Liang HD; Dong B; Lu QL; Blomley MJ
Radiology; 2005 Oct; 237(1):224-9. PubMed ID: 16081853
[TBL] [Abstract][Full Text] [Related]
16. Ultrasound microbubble contrast agents: application to therapy for peripheral vascular disease.
Hu YZ; Zhu JA; Jiang YG; Hu B
Adv Ther; 2009 Apr; 26(4):425-34. PubMed ID: 19381521
[TBL] [Abstract][Full Text] [Related]
17. Detection procedures of ultrasound contrast agents.
de Jong N; Frinking PJ; Bouakaz A; Ten Cate FJ
Ultrasonics; 2000 Mar; 38(1-8):87-92. PubMed ID: 10829635
[TBL] [Abstract][Full Text] [Related]
18. [Contrast-enhanced power Doppler imaging of the liver--preliminary animal study].
Matsumura T; Moriyasu F; Kono Y; Chiba T
Nihon Rinsho; 1998 Apr; 56(4):985-9. PubMed ID: 9577621
[TBL] [Abstract][Full Text] [Related]
19. Clinical experience with sonographic contrast agents.
Melany ML; Grant EG
Semin Ultrasound CT MR; 1997 Feb; 18(1):3-12. PubMed ID: 9143061
[TBL] [Abstract][Full Text] [Related]
20. Overview of echo-enhanced vascular ultrasound imaging for clinical diagnosis in neurosonology.
Burns PN
J Neuroimaging; 1997 Apr; 7 Suppl 1():S2-14. PubMed ID: 9128460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
